Biocon MD Kiran Mazumdar-Shaw Named EY World Entrepreneur Of The Year

Kiran Mazumdar Shaw, Executive Chairperson and Managing Director of Limited, has been named EY World Entrepreneur Of The Year for 2020.

The MD was picked from among 46 nominations from 41 countries.

She also becomes the second woman to hold the title, following Olivia Lum of Hyflux Limited from Singapore in 2011.

Kiran, 67, founded Biocon, a bio-enzymes company, in 1978 with just two employees and $500. The company is now employs more than 11,000 people.

“My business focus is global health care and the provision of universal access to life saving medicine; however, my responsibility as an entrepreneur is greater than simply delivering value to shareholders. Wealth creation can be a catalyst for change, and all entrepreneurs have a responsibility to the world around them and the communities in which they operate," Shaw said after the award announcement.

ALSO READ: Buy Sun Pharma June Futures at Rs 496: Nandish Shah of HDFC Securities

"Women also play a hugely important role in economic development, and for too long their contribution has been ignored. It’s important that we use the platform of EY World Entrepreneur Of The Year to encourage more women to participate in entrepreneurial pursuits. I’m truly honored to receive this prestigious award," she added.

She is the third award winner from India. Managing Director of Kotak Mahindra Bank, Uday Kotak (2014) and Infosys founder Narayana Murthy (2005) are the former recipients.

Manny Stul, Chairman and Co-CEO of Moose Toys and Chair of the EY World Entrepreneur Of The Year judging panel, says, "Kiran is an inspirational entrepreneur who demonstrates that determination, perseverance and a willingness to innovate can create long-term value. The judging panel were impressed by her ability to build and sustain growth over the past 30 years and by her integrity and passion for philanthropy that has delivered huge global impact. She has built India’s largest biopharmaceutical company on a foundation of compassionate capitalism and putting patient needs before profits.”

“Dr Shaw’s recognition is a moment of tremendous pride for Indian entrepreneurship. She is truly a winner on several counts - not only has she shown tremendous vision and fortitude to grow into a market-leading, innovation-driven biotechnology organization which has created a global impact, but she has also made her mark as a torchbearer of diversity, a voice of Indian industry and a frontrunner in philanthropy and giving back to the society,” said Rajiv Memani, EY India Chairman and Regional Managing Partner.

RECENT NEWS

JPMorgan Deploys AI Chatbot To Revolutionize Research And Productivity

JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more

Private Equity And Banks: The Complex Web Of Leverage

Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more

Financial Watchdog Highlights Unresolved Vulnerabilities In Shadow Banking Sector

The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more

JPMorgan And Small Caps Lead Market Rally: A Sign Of Economic Optimism

In a week marked by strong financial performance, JPMorgan Chase & Co. reported a 25% rise in profits, and US small-... Read more

Big Banks Vs. Regional Banks: The Battle For Market Share

The financial industry is a competitive landscape where big banks and regional banks vie for market share. Each type of ... Read more

The Evolution Of Philanthropic Advisory Services In Private Banks

The landscape of philanthropic advisory services provided by private banks has undergone a significant transformation. T... Read more